The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales

Research output: Contribution to journalArticlepeer-review


  • Eoghan M McCarthy
  • Emily Sutton
  • Stephanie Nesbit
  • Ben Parker
  • David Jayne
  • Bridget Griffiths
  • David A Isenberg
  • Anisur Rahman
  • Caroline Gordon
  • David P D'Cruz
  • Benjamin Rhodes
  • Peter Lanyon
  • Edward M Vital
  • Chee-Seng Yee
  • Christopher J Edwards
  • Lee-Suan Teh
  • Mohammed Akil
  • Neil J McHugh
  • Asad Zoma
  • Ian N Bruce
  • British Isles Lupus Assessment Group Biologics Register

Colleges, School and Institutes

External organisations

  • Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK The Kellgren Centre for Rheumatology, NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • University of Manchester
  • Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
  • Department of Rheumatology, Freeman Hospital, Newcastle upon Tyne.
  • University College London
  • Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Queen Elizabeth Hospital, Birmingham.
  • Louise Coote Lupus Unit, Guys Hospital, London.
  • Rheumatology Department-University Hospitals Birmingham NHS Foundation Trust, Old Queen Elizabeth Hospital, Birmingham.
  • Rheumatology Department, Nottingham University Hospitals NHS Trust, Nottingham.
  • University of Leeds
  • Department of Rheumatology, Doncaster and Bassetlaw Hospitals NHS Foundation Trust, Doncaster
  • Musculoskeletal Research Unit, NIHR Wellcome Trust Clinical Research facility, The University of Southampton.
  • Department of Rheumatology, Royal Blackburn Hospital, Blackburn.
  • Rheumatology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield.
  • Department of Rheumatology, Royal National Hospital for Rheumatic Diseases and Royal United Hospitals Bath NHS Foundation Trust.
  • Rheumatology Department, Hairmyres Hospital, Lanarkshire, UK.


Original languageEnglish
Pages (from-to)1049
Issue number6
Early online date22 May 2017
Publication statusPublished - 1 Jun 2017


  • national health service (uk), country of wales, guidelines , rituximab , belimumab